Key Takeaways From Boston Scientific Analyst RatingsBenzinga • 1 day ago
Latest Ratings for BSX
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform
View More Analyst...
Share to Feed
read more...
Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in the large medical device market also pose a tough...
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE Nav Pulsed Field Ablation Catheter and FARAVIEW Software Module Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE Nav Pulsed...
Boston Scientific (NYSE:BSX - Free Report) had its target price boosted by Citigroup from $71.00 to $79.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Citigroup...
Boston Scientific Co. (NYSE:BSX - Get Free Report) EVP John Bradley Sorenson sold 16,351 shares of the firm's stock in a transaction dated Monday, April 1st. The stock was sold at an average price of...
Breakwater Capital Group increased its stake in Boston Scientific Co. (NYSE:BSX - Free Report) by 8.3% during the fourth quarter, according to the company in its most recent disclosure with the...
Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Latest Ratings for BSX
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022Raymond JamesMaintainsStrong Buy Feb 2022SVB LeerinkMaintainsMarket Perform
View More Analyst...